CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in BMY — Bristol Myers Squibb Co
CIK 884546
SAN FRANCISCO, CA
Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,894,834,098
+$188,186,726 QoQ
Shares Held
67,595,177
+10.6% QoQ
Ownership
3.31%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#5
of 2,514 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $34,394,076,697 across 15 Drug Manufacturers - General names. BMY ranks #5 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,001,955 | $7,198,925,485 | |
| 2 | MRK |
Merck & Co., Inc.
|
54,365,289 | $6,985,939,635 | |
| 3 | AMGN |
Amgen Inc
|
15,034,038 | $5,444,125,839 | |
| 4 | JNJ |
Johnson & Johnson
|
19,126,165 | $4,857,472,124 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
67,595,177 | $3,894,834,098 | |
| 6 | ABBV |
AbbVie Inc.
|
12,914,230 | $3,249,736,836 | |
| 7 | PFE |
Pfizer Inc
|
52,548,228 | $1,265,361,329 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,155,281 | $1,030,338,200 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,894,834,098 | 67,595,177 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,706,647,372 | 61,115,373 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $3,847,129,824 | 71,322,392 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,294,118,567 | 73,040,323 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,277,456,057 | 70,802,680 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,696,415,135 | 60,606,905 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $3,410,594,866 | 60,300,475 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $3,157,713,051 | 61,030,403 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,452,831,321 | 59,061,674 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,913,016,836 | 53,715,966 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $582,969,699 | 11,361,717 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $651,609,392 | 11,226,902 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $717,888,247 | 11,225,774 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $786,908,728 | 11,353,466 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $806,350,773 | 11,207,099 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $791,673,311 | 11,136,212 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $833,505,442 | 10,824,746 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $803,729,693 | 11,005,473 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $673,908,291 | 10,808,473 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $631,904,003 | 10,679,466 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $691,800,890 | 10,353,201 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $640,675,941 | 10,148,518 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $652,596,663 | 10,520,662 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $633,099,924 | 10,500,911 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $656,371,993 | 11,162,789 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $1,093,717,961 | 19,621,779 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||